INS and Hyperglycemia: Reducing basal insulin dosage by 15–30% with appropriate adjustments of prandial insulin for MDI regimen (or reducing the Suhoor dose by 25–50% for twice‐daily premixed insulin) could have minimized the risk of mild‐to‐moderate hypoglycemia, but not severe hypoglycemia and hyperglycemia/ketosis, as shown in the present meta‐analysis1.